PeerVoice

PeerVoice Clinical Pharmacology Audio

Science EN ↓ 200 episodes

PeerVoice is committed to producing and distributing evidence-based, independently-created medical education in Clinical Pharmacology that is designed to positively impact patient care. Activities can either be accredited or non-accredited but are always driven by the learning and practice needs of healthcare professionals. Learn more at: https://peervoice.com.

Author

PeerVoice

Category

Science

Podcast website

www.peervoice.com

Latest episode

Jun 29, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Anil K. Gupta, MD, CCFP, FCFP / Nathan Peiffer-Smadja, MD, PhD - Steps Towards Preventing COVID-19 Variants: Because Every Individual Counts 13.12.2022

Anil K. Gupta, MD, CCFP, FCFP / Nathan Peiffer-Smadja, MD, PhD - Steps Towards Preventing COVID-19 Variants: Because Every Individual Counts

Ewa A. Jankowska, MD, PhD - Breakthroughs and Game-Changers in Heart Failure 06.12.2022

Ewa A. Jankowska, MD, PhD - Breakthroughs and Game-Changers in Heart Failure

Melanie J. Davies, CBE, FRCP, FMedSci - Proactive Stroke Risk Mitigation Strategies: Taking Aim in Type 2 Diabetes 05.12.2022

Melanie J. Davies, CBE, FRCP, FMedSci - Proactive Stroke Risk Mitigation Strategies: Taking Aim in Type 2 Diabetes

Janaka Karalliedde, FRCP, PhD - Stroke Prevention in T2DM: The Neuroprotective Benefits of GLP-1 RAs 05.12.2022

Janaka Karalliedde, FRCP, PhD - Stroke Prevention in T2DM: The Neuroprotective Benefits of GLP-1 RAs

Kjeld Schmiegelow, MD, DMSci - Asparaginase Therapy in Children and Young Adults With ALL/LBL: When You Need to Switch 05.12.2022

Kjeld Schmiegelow, MD, DMSci - Asparaginase Therapy in Children and Young Adults With ALL/LBL: When You Need to Switch

Marla C. Dubinsky, MD - Most Patients With Ulcerative Colitis ‘Can’t Wait’: The Impact and Clinical Assessment of Bowel Urgency 29.11.2022

Marla C. Dubinsky, MD - Most Patients With Ulcerative Colitis ‘Can’t Wait’: The Impact and Clinical Assessment of Bowel Urgency

Anton Pozniak, MD, FRCP - Resistance is Futile: Achieving and Maintaining HIV Viral Suppression 24.11.2022

Anton Pozniak, MD, FRCP - Resistance is Futile: Achieving and Maintaining HIV Viral Suppression

Luke Stephen Prockter Moore, FRCP, FRCPath, PhD - A Cohesive Multidisciplinary Approach to Antimicrobial Stewardship: Joining the Dots on Rapid Diagnostic Testing 24.11.2022

Luke Stephen Prockter Moore, FRCP, FRCPath, PhD - A Cohesive Multidisciplinary Approach to Antimicrobial Stewardship: Joining the Dots on Rapid Diagnostic Testing

Paolo Ventura, MD - Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics 23.11.2022

Paolo Ventura, MD - Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics

Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes? 17.11.2022

Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes?

Wytske Fokkens, MD, PhD - Biologics for CRSwNP Management: Your Questions Answered 14.11.2022

Wytske Fokkens, MD, PhD - Biologics for CRSwNP Management: Your Questions Answered

José R. Arribas, MD - Mastering the Management of Multidrug-Resistant HIV: When, With What, and How 07.11.2022

José R. Arribas, MD - Mastering the Management of Multidrug-Resistant HIV: When, With What, and How

Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice 03.10.2022

Expert Guidance for Improving Outcomes in Advanced NSCLC: Utilising ADCs in Practice

Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC 29.09.2022

Right Drug, Right Patient, Right Time: Cases in “Precisionalised” Treatment of Advanced NSCLC

Managing Cytopenic Myelofibrosis: New and Emerging Therapies and Who May Benefit 29.09.2022

Managing Cytopenic Myelofibrosis: New and Emerging Therapies and Who May Benefit

Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART? 20.09.2022

Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?

Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care 07.09.2022

Reassessing Management of Advanced and Recurrent Endometrial Cancer: The Value of Multidisciplinary and Overall Care

Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions 07.09.2022

Personalised Management of Newly Diagnosed Secondary Acute Myeloid Leukaemia: Determining Factors That Impact Treatment Decisions

Question Time: Applying New Therapies for the Management of mTNBC 29.08.2022

Question Time: Applying New Therapies for the Management of mTNBC

New Biomarkers, New Targets in Advanced NSCLC 17.08.2022

New Biomarkers, New Targets in Advanced NSCLC

Managing Generalised Myasthenia Gravis: A Tale of Two Targets 10.08.2022

Managing Generalised Myasthenia Gravis: A Tale of Two Targets

Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias 01.08.2022

Addressing the Triple Challenge of Myelofibrosis: Symptoms, Splenomegaly, and Cytopenias

Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC 11.07.2022

Practical Guidance for Identifying and Managing Patients With Advanced MET Exon 14-Skipping NSCLC

Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022 30.06.2022

Insights on the Increasing Impact of Emerging Therapies in NSCLC: Highlights From Spring 2022

How I Treat: Achieving Healing in CPF 07.06.2022

How I Treat: Achieving Healing in CPF

Listen to the PeerVoice Clinical Pharmacology Audio podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.